Difference between revisions of "Neurodegenerative diseases"
Jump to navigation
Jump to search
(→Alzheimer disease: more) |
|||
| Line 282: | Line 282: | ||
*Abbreviated ''ALS''. | *Abbreviated ''ALS''. | ||
*Weakness. | *Weakness. | ||
==Parkinson disease== | |||
===General=== | |||
*Common. | |||
===Gross=== | |||
Features:<ref name=Ref_PBoD8_1319>{{Ref PBoD8|1319}}</ref> | |||
*Abnormally pale substantia nigra | |||
**Substantia nigra in the midbrain. | |||
===Microscopic=== | |||
Features:<ref name=Ref_PBoD8_1319>{{Ref PBoD8|1319}}</ref> | |||
*Loss of pigmented (catecholaminergic) neurons in the substantia nigra. | |||
*Gliosis - due to neuron loss. | |||
==Prion diseases== | ==Prion diseases== | ||